Department of Pharmaceutical Chemistry, Faculty of Pharmacy, El saleheya El Gadida University, Cambridge, Egypt.
Department of Chemistry, University of Cambridge, Cambridge, United Kingdom.
J Enzyme Inhib Med Chem. 2022 Dec;37(1):2256-2264. doi: 10.1080/14756366.2022.2114079.
In searching for new molecular drug targets, Carbonic Anhydrases (CAs) have emerged as valuable targets in diverse diseases. CAs play critical functions in maintaining pH and CO homeostasis, metabolic pathways, and much more. So, it is becoming attractive for medicinal chemists to design novel inhibitors for this class of enzymes with improved potency and selectivity towards the different isoforms. In the present study, three sets of carboxylic acid derivatives , and were designed, developed and evaluated for the hCA inhibitory effects against hCA I, II, IX and XII. Compounds and elicited the highest inhibitory activities against hCA II, IX and XII. In summary, structural rigidification, regioisomerism and structural extension, all played obvious roles in the degree of hCA inhibition. This present work could be a good starting point for the design of more non-classical selective hCA inhibitors as potential targets for several diseases.
在寻找新的分子药物靶点时,碳酸酐酶 (CA) 已成为多种疾病中有价值的靶点。CA 在维持 pH 值和 CO2 平衡、代谢途径等方面发挥着关键作用。因此,设计新型抑制剂以提高对不同同工型的效力和选择性,对于药物化学家来说变得具有吸引力。在本研究中,设计、开发和评估了三组羧酸衍生物 、和,以评估它们对 hCA I、II、IX 和 XII 的抑制作用。化合物和对 hCA II、IX 和 XII 的抑制活性最高。总之,结构刚性化、区域异构体和结构延伸都在 hCA 抑制程度方面发挥了明显的作用。本工作可为设计更多作为几种疾病潜在靶点的非经典选择性 hCA 抑制剂提供良好的起点。